Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.

Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, Berchuck A, Pearce CL, Pike M, Ness RB, Webb PM; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Rossing MA, Schildkraut J, Risch H, Goodman MT; Ovarian Cancer Association Consortium.

Cancer Prev Res (Phila). 2013 Aug;6(8):811-21. doi: 10.1158/1940-6207.CAPR-13-0037. Epub 2013 Jun 12.

2.

Genital powder exposure and the risk of epithelial ovarian cancer.

Rosenblatt KA, Weiss NS, Cushing-Haugen KL, Wicklund KG, Rossing MA.

Cancer Causes Control. 2011 May;22(5):737-42. doi: 10.1007/s10552-011-9746-3. Epub 2011 Mar 10.

3.

Perineal powder exposure and the risk of ovarian cancer.

Cook LS, Kamb ML, Weiss NS.

Am J Epidemiol. 1997 Mar 1;145(5):459-65. Erratum in: Am J Epidemiol 1998 Aug 15;148(4):410.

PMID:
9048520
4.

The Association Between Talc Use and Ovarian Cancer: A Retrospective Case-Control Study in Two US States.

Cramer DW, Vitonis AF, Terry KL, Welch WR, Titus LJ.

Epidemiology. 2016 May;27(3):334-46. doi: 10.1097/EDE.0000000000000434.

5.

Genital talc exposure and risk of ovarian cancer.

Cramer DW, Liberman RF, Titus-Ernstoff L, Welch WR, Greenberg ER, Baron JA, Harlow BL.

Int J Cancer. 1999 May 5;81(3):351-6.

6.

Perineal exposure to talc and ovarian cancer risk.

Harlow BL, Cramer DW, Bell DA, Welch WR.

Obstet Gynecol. 1992 Jul;80(1):19-26. Review.

PMID:
1603491
7.

Perineal powder use and risk of ovarian cancer.

Houghton SC, Reeves KW, Hankinson SE, Crawford L, Lane D, Wactawski-Wende J, Thomson CA, Ockene JK, Sturgeon SR.

J Natl Cancer Inst. 2014 Sep 10;106(9). pii: dju208. doi: 10.1093/jnci/dju208. Print 2014 Sep.

8.

Perineal talc exposure and risk of ovarian carcinoma.

Chang S, Risch HA.

Cancer. 1997 Jun 15;79(12):2396-401.

PMID:
9191529
9.

Prospective study of talc use and ovarian cancer.

Gertig DM, Hunter DJ, Cramer DW, Colditz GA, Speizer FE, Willett WC, Hankinson SE.

J Natl Cancer Inst. 2000 Feb 2;92(3):249-52.

PMID:
10655442
10.

Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of California.

Mills PK, Riordan DG, Cress RD, Young HA.

Int J Cancer. 2004 Nov 10;112(3):458-64.

11.
12.

Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.

Wong C, Hempling RE, Piver MS, Natarajan N, Mettlin CJ.

Obstet Gynecol. 1999 Mar;93(3):372-6.

PMID:
10074982
13.

Association between Body Powder Use and Ovarian Cancer: The African American Cancer Epidemiology Study (AACES).

Schildkraut JM, Abbott SE, Alberg AJ, Bandera EV, Barnholtz-Sloan JS, Bondy ML, Cote ML, Funkhouser E, Peres LC, Peters ES, Schwartz AG, Terry P, Crankshaw S, Camacho F, Wang F, Moorman PG.

Cancer Epidemiol Biomarkers Prev. 2016 Oct;25(10):1411-1417. Epub 2016 May 12.

PMID:
27197282
14.

Ovarian cancer and talc: a case-control study.

Cramer DW, Welch WR, Scully RE, Wojciechowski CA.

Cancer. 1982 Jul 15;50(2):372-6.

15.

Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.

Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, Schildkraut JM, Berchuck A, Olson SH, Kiemeney LA, Massuger LF, Narod SA, Phelan CM, Anton-Culver H, Ziogas A, Wu AH, Pearce CL, Risch HA, Jensen A; , on behalf of the Ovarian Cancer Association Consortium.

Am J Epidemiol. 2017 Jan 1;185(1):8-20. doi: 10.1093/aje/kww161. Epub 2016 Dec 9. Review.

PMID:
27941069
16.

Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee.

Whittemore AS, Wu ML, Paffenbarger RS Jr, Sarles DL, Kampert JB, Grosser S, Jung DL, Ballon S, Hendrickson M.

Am J Epidemiol. 1988 Dec;128(6):1228-40.

PMID:
3195564
17.

Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Goodman MT, Lurie G, Chang-Claude J, Rudolph A, Kjær SK, Jensen A, Høgdall E, Bandera EV, Olson SH, King MG, Rodriguez-Rodriguez L, Kiemeney LA, Marees T, Massuger LF, van Altena AM, Ness RB, Cramer DW, Pike MC, Pearce CL, Berchuck A, Schildkraut JM, Whittemore AS; Ovarian Cancer Association Consortium.

Int J Epidemiol. 2013 Apr;42(2):579-89. doi: 10.1093/ije/dyt042.

18.

Cigarette smoking and risk of epithelial ovarian cancer.

Rossing MA, Cushing-Haugen KL, Wicklund KG, Weiss NS.

Cancer Causes Control. 2008 May;19(4):413-20. Epub 2007 Dec 15.

PMID:
18080774
19.

Perineal application of talc and cornstarch powders: evaluation of ovarian cancer risk.

Whysner J, Mohan M.

Am J Obstet Gynecol. 2000 Mar;182(3):720-4. Review.

PMID:
10739536
20.

Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.

Merritt MA, De Pari M, Vitonis AF, Titus LJ, Cramer DW, Terry KL.

Hum Reprod. 2013 May;28(5):1406-17. doi: 10.1093/humrep/des466. Epub 2013 Jan 12.

Supplemental Content

Support Center